OSTF1
From Wikipedia, the free encyclopedia
|
Osteoclast stimulating factor 1
|
||||||||||||||
| PDB rendering based on 1x2k. | ||||||||||||||
| Available structures: 1x2k, 1zlm | ||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | OSTF1; FLJ20559; OSF; SH3P2; bA235O14.1 | |||||||||||||
| External IDs | OMIM: 610180 MGI: 700012 HomoloGene: 8227 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 26578 | 20409 | ||||||||||||
| Ensembl | ENSG00000134996 | ENSMUSG00000024725 | ||||||||||||
| Uniprot | Q92882 | Q62422 | ||||||||||||
| Refseq | NM_012383 (mRNA) NP_036515 (protein) |
NM_017375 (mRNA) NP_059071 (protein) |
||||||||||||
| Location | Chr 9: 76.89 - 76.95 Mb | Chr 19: 18.65 - 18.67 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Osteoclast stimulating factor 1, also known as OSTF1, is a human gene.[1]
[edit] References
[edit] Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.". Gene 138 (1-2): 171-4. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library.". Gene 200 (1-2): 149-56. PMID 9373149.
- Sparks AB, Hoffman NG, McConnell SJ, et al. (1998). "Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.". Nat. Biotechnol. 14 (6): 741-4. doi:. PMID 9630982.
- Reddy S, Devlin R, Menaa C, et al. (1999). "Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.". J. Cell. Physiol. 177 (4): 636-45. doi:. PMID 10092216.
- Schaub R, Dupont B, Roodman GD, et al. (2000). "Assignment of OSTF1 to human chromosome bands 12q24.1-->q24.2 by in situ hybridization.". Cytogenet. Cell Genet. 88 (1-2): 87-8. PMID 10773673.
- Kurihara N, Menaa C, Maeda H, et al. (2001). "Osteoclast-stimulating factor interacts with the spinal muscular atrophy gene product to stimulate osteoclast formation.". J. Biol. Chem. 276 (44): 41035-9. doi:. PMID 11551898.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Szymkiewicz I, Destaing O, Jurdic P, Dikic I (2004). "SH3P2 in complex with Cbl and Src.". FEBS Lett. 565 (1-3): 33-8. doi:. PMID 15135048.
- Humphray SJ, Oliver K, Hunt AR, et al. (2004). "DNA sequence and analysis of human chromosome 9.". Nature 429 (6990): 369-74. doi:. PMID 15164053.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:. PMID 15489334.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network.". Nature 437 (7062): 1173-8. doi:. PMID 16189514.
- Li M, Meng Z, Xu Y, et al. (2006). "Crystallization and preliminary X-ray crystallographic analysis of osteoclast-stimulating factor.". Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 61 (Pt 1): 128-30. doi:. PMID 16508112.
- Chen L, Wang Y, Wells D, et al. (2006). "Structure of the SH3 domain of human osteoclast-stimulating factor at atomic resolution.". Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62 (Pt 9): 844-8. doi:. PMID 16946461.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635-48. doi:. PMID 17081983.
- Ewing RM, Chu P, Elisma F, et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry.". Mol. Syst. Biol. 3: 89. doi:. PMID 17353931.

